Home  |  Contact

UniProtKB/Swiss-Prot Q5T6L9: Variant p.Ile377Asn

Endoplasmic reticulum membrane-associated RNA degradation protein
Gene: ERMARD
Variant information

Variant position:  377
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Isoleucine (I) to Asparagine (N) at position 377 (I377N, p.Ile377Asn).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (I) to medium size and polar (N)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Periventricular nodular heterotopia 6 (PVNH6) [MIM:615544]: A form of periventricular nodular heterotopia, a disorder resulting from a defect in the pattern of neuronal migration in which ectopic collections of neurons lie along the lateral ventricles of the brain or just beneath, contiguously or in isolated patches. PVNH6 results in delayed psychomotor development, delayed speech, strabismus, and onset of seizures with hypsarrhythmia in early infancy. {ECO:0000269|PubMed:24056535}. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In PVNH6; may decrease protein stability.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  377
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  678
The length of the canonical sequence.

Location on the sequence:   WDFLNHQEGPRIRDHLSHGE  I NLHEFSKETTNQLLAFSLVL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         WDFLNHQEGPRIRDHLSHGEINLHEFSKETTNQLLAFSLVL

Rat                           WDFLNYQEGPRIRDRLSHGEINIREFPKAAASQLLTFCLVL

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 678 Endoplasmic reticulum membrane-associated RNA degradation protein


Literature citations

Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene.
Conti V.; Carabalona A.; Pallesi-Pocachard E.; Parrini E.; Leventer R.J.; Buhler E.; McGillivray G.; Michel F.J.; Striano P.; Mei D.; Watrin F.; Lise S.; Pagnamenta A.T.; Taylor J.C.; Kini U.; Clayton-Smith J.; Novara F.; Zuffardi O.; Dobyns W.B.; Scheffer I.E.; Robertson S.P.; Berkovic S.F.; Represa A.; Keays D.A.; Cardoso C.; Guerrini R.;
Brain 136:3378-3394(2013)
Cited for: VARIANT PVNH6 ASN-377; FUNCTION; SUBCELLULAR LOCATION;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.